Twitter
Session
Committees
Groups
Constituency Week
Conciliation Committee
02.03.2010
09:00 - 15:30
Patient Empowerment A New Paradigm in Disease Management?
MEP Dr. Jorgo Chatzimarkakis
60, rue Wiertz
B-1047 Brussels, Belgium
Phone: +32 2 28 45149
Fax: +32 2 28 49149
Email: jorgo.chatzimarkakis@europarl.europa.eu
Link to the organizer
09:00 - 15:30
Patient Empowerment A New Paradigm in Disease Management?
MEP Dr. Jorgo Chatzimarkakis
60, rue Wiertz
B-1047 Brussels, Belgium
Phone: +32 2 28 45149
Fax: +32 2 28 49149
Email: jorgo.chatzimarkakis@europarl.europa.eu
Link to the organizer
Conference / Convention
Type of Event
Health
Policy Field of Event
Registration required
Limitation
European Parliament, PHS, 4B001
Rue Wiertz 60
1047 Brussels
Rue Wiertz 60
1047 Brussels
Location of event
The European Life Science Circle (ELSC) was launched
in 2006 by Dr. Jorgo Chatzimarkakis, Member
of the European Parliament to facilitate the dialogue
with interested stakeholders on relevant issues in the context of life science and pharmaceuticals.
Empowering chronic patients to take responsibility for the day to day management of their disease is believed to significantly enhance the medical outcome. Patients who are empowered to act self-responsibly may also contribute to lowering the costs of health care by avoiding costly and potentially life-threatening complications and co-morbidities. Case in point: cardiovascular- and kidney diseases, diabetes and asthma, common chronic diseases in Europe.
- How can patients influence the course of their disease?
- And how can health systems use patient empowerment to improve the medical and economic outcome of their disease management?
in 2006 by Dr. Jorgo Chatzimarkakis, Member
of the European Parliament to facilitate the dialogue
with interested stakeholders on relevant issues in the context of life science and pharmaceuticals.
Empowering chronic patients to take responsibility for the day to day management of their disease is believed to significantly enhance the medical outcome. Patients who are empowered to act self-responsibly may also contribute to lowering the costs of health care by avoiding costly and potentially life-threatening complications and co-morbidities. Case in point: cardiovascular- and kidney diseases, diabetes and asthma, common chronic diseases in Europe.
- How can patients influence the course of their disease?
- And how can health systems use patient empowerment to improve the medical and economic outcome of their disease management?
Infos
Dr. Jorgo Chatzimarkakis, Member of the European Parliament; Prof. Dr. Ad A. Kaptein, Professor for Medical Psychology, Leiden University Medical Centre; António Correia De Campos, Member of the European Parliament.
People
